Net (Loss) Income: The net loss attributable to Serina for the three months ended September 30, 2025 was $4.6 million, or $0.45 per basic and diluted share, compared to net income of $1.4 million, or ...
Serina Therapeutics, Inc. ("Serina" or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New ...
1 Day JPM -3.41% DJIA -1.65% S&P 500 -1.66% Financial Services -1.56% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback